Neoadjuvant immunotherapy in patients with resectable non-small cell lung cancer Editorial


Authors: Broderick, S. R.; Bott, M. J.
Title: Neoadjuvant immunotherapy in patients with resectable non-small cell lung cancer
Keywords: cancer survival; event free survival; protein expression; treatment response; primary tumor; gene mutation; postoperative period; placebo; cancer combination chemotherapy; diarrhea; drug efficacy; drug safety; comparative study; disease free survival; neoadjuvant therapy; cancer staging; follow up; prospective study; cd8+ t lymphocyte; t lymphocyte; disease association; ipilimumab; cancer immunotherapy; metastasis; progression free survival; computer assisted tomography; breast cancer; thoracotomy; vomiting; morbidity; editorial; pneumonia; postoperative complication; intensive care unit; t lymphocyte receptor; blood analysis; antigen recognition; operation duration; single drug dose; hospital admission; cytotoxic t lymphocyte antigen 4; convalescence; empyema; atrial fibrillation; cell expansion; video assisted thoracoscopic surgery; endocrine disease; artificial ventilation; programmed death 1 ligand 1; non small cell lung cancer; tumor microenvironment; randomized controlled trial (topic); clinical trial (topic); adverse event; phase 2 clinical trial (topic); phase 3 clinical trial (topic); wedge resection; endoleak; adjuvant chemoradiotherapy; nivolumab; operative blood loss; human; priority journal; pembrolizumab; immunostimulating agent; durvalumab; loss of appetite; robot assisted surgery; atezolizumab
Journal Title: Journal of Thoracic and Cardiovascular Surgery
Volume: 158
Issue: 5
ISSN: 0022-5223
Publisher: Mosby Elsevier  
Date Published: 2019-11-01
Start Page: 1471
End Page: 1474
Language: English
DOI: 10.1016/j.jtcvs.2019.06.114
PUBMED: 31623813
PROVIDER: scopus
DOI/URL:
Notes: Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Matthew Bott
    135 Bott